Phosphate and Inflammation in Health and Kidney Disease

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Biochemistry

Background:

• Phosphate overload is a key driver of vascular injury and oxidative stress in chronic kidney disease (CKD).
• The
• Phosphatopathy
• framework links phosphate overload to systemic inflammation, endothelial dysfunction, and vascular calcification.

Purpose of the Study:

• To elucidate the mechanisms by which phosphate overload induces oxidative stress and vascular damage in CKD.
• To identify biomarkers and therapeutic targets for managing phosphate-induced pathology.

Main Methods:

• Review of experimental and clinical data on phosphate metabolism and its vascular effects in CKD.
• Analysis of signaling pathways including NOX-ROS, Wnt/β-catenin, TGF-β, and FGF23-Klotho axis.
• Evaluation of the phosphate/urinary urea nitrogen (P/UUN) ratio as a biomarker.

Main Results:

• Phosphate overload activates NOX-derived ROS, disrupts the FGF23-Klotho axis, and promotes endothelial dysfunction, vascular calcification, and left ventricular hypertrophy (LVH).
• The P/UUN ratio is a sensitive biomarker of phosphate load.
• MicroRNA-125b and calciprotein particles are emerging regulators of phosphate-driven responses.

Conclusions:

• Phosphate is a modifiable upstream trigger of oxidative and metabolic stress in CKD, contributing to the malnutrition-inflammation-atherosclerosis (MIA) syndrome.
• Therapeutic strategies should focus on reducing phosphate burden through dietary changes, non-calcium binders, and supplementation.
• Targeting phosphate load and redox imbalance offers a convergent approach to prevent vascular calcification and reduce cardiovascular risk in CKD patients.